SAN DIEGO, March 25, 2025 /PRNewswire/ — Adcentrx Therapeutics (“Adcentrx”), a clinical-stage biotechnology company ... stage STEAP1 ADC, and a poster presentation on ADRX-0134, its ...

Poster highlights potential predictive biomarker ... of-care regimen of existing checkpoint inhibitors. About MAIA Biotechnology, Inc. MAIA is a targeted therapy, immuno-oncology company focused ...

CHICAGO, March 25, 2025--(BUSINESS WIRE)--MAIA Biotechnology ... predictive biomarker for THIO treatment was selected for poster presentation at the European Lung Cancer Congress 2025 (ELCC ...

MAIA Biotechnology, Inc., (NYSE American ... a potential predictive biomarker for THIO treatment was selected for poster presentation at the European Lung Cancer Congress 2025 (ELCC 2025) taking ...

CHICAGO, March 25, 2025--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American ... detailing a potential predictive biomarker for THIO treatment was selected for poster presentation at the ...